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Dystroglycan (DG) is a transmembrane receptor linking the extracellular matrix to the internal cytoskeleton. Its structural function has been
mainly characterized in muscle fibers, but DG plays signaling and developmental roles also in different tissues and cell types. We have
investigated the effects of dystroglycan depletion during eye development of Xenopus laevis. We have injected a specific morpholino (Mo)
antisense oligonucleotide in the animal pole of one dorsal blastomere of embryos at four cells stage. Mo-mediated loss of DG function caused
disruption of the basal lamina layers, increased apoptosis and reduction of the expression domains of specific retinal markers, at early stages. Later
in development, morphants displayed unilateral ocular malformations, such as microphtalmia and retinal delayering with photoreceptors and
ganglion cells scattered throughout the retina or aggregated in rosette-like structures. These results recall the phenotypes observed in specific
human diseases and suggest that DG presence is crucial at early stages for the organization of retinal architecture.
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Dystroglycan (DG) is a central component of the dystro-
phin-associated protein complex (DAP) that is deeply disorga-
nized in muscles of patients with congenital muscular
dystrophies. Damage of muscle fibers is often associated with
ophthalmic and central nervous system anomalies in severe
forms of disease, such as Duchenne Muscular Dystrophy,
where mutations of the dystrophin gene lead to destabilization
of the DAP complex. In different tissues, distinct variants of
DAP complexes are presents, but in each case, DG is always
the principal receptor, playing the important role of linking
extracellular matrix (ECM) proteins to intracellular cytoskel-
eton (Winder, 2001).
Patients with other congenital muscular dystrophies, such as
Walker–Warburg syndrome (WWS), muscle–eye–brain
(MEB) disease, Fukuyama congenital muscular dystrophy
(FCMD), also suffer from muscular dystrophy, eye abnormal-0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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99, 34012 Trieste, Italy.ities and CNS neuronal migration defects(Dubowitz, 2000;
Hayashi et al., 2001; Kano et al., 2002; Michele et al., 2002;
Toda et al., 2000). In this group of diseases, specific glycosyl-
transferase enzymes are affected and DG is hypoglycosylated
(Muntoni et al., 2002) Indeed, proper glycosylation of DG is
essential for specific binding to a variety of ECM proteins such
as laminin, agrin or perlecan (Endo and Toda, 2003) (Toda et
al., 2000).
DG is produced as a precursor polypeptide that is processed
into two interacting a and h subunits. a-DG is extracellular
and is extensively glycosylated in a tissue-specific manner, h-
DG is a transmembrane protein that binds to dystrophin and
other intracellular proteins (Winder, 2001). Alterations of the
glycosylation pattern impair the function of a-DG in binding to
ECM proteins and, as a consequence, influences signal
transduction and connection to cytoskeletal proteins mediated
by h-DG. Animal models, such as mydLarge mice, where DG
glycosylation carried out by Large protein was impaired,
showed similarities to the heterogeneous group of human
muscle–eye–brain diseases listed above (Kanagawa et al.,
2004; Michele et al., 2002).
Furthermore, targeted DG depletion in mouse brain pro-
voked even more severe pathological features, including90 (2006) 411 – 420
www.e
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aberrant migration of granule cells, associated with loss of
ability to organize the basal lamina of the glia limitans (Moore
et al., 2002). On the other hand, full removal of DG in
knockout mice resulted in embryonic death, because assembly
of pivotal basement membrane (Reichert’s membrane) was
impaired (Williamson et al., 1997).
All these data, and others that directly prove DG involve-
ment in basal laminae assembly, strongly support a crucial role
for DG in early development and in the morphogenesis of
neuroepithelial tissues. The vertebrate retina is part of the
central nervous system (CNS) and like other CNS structures is
characterized by a layered architecture containing distinct cell
types. Therefore, it is a useful model to study mechanisms of
CNS differentiation and morphogenesis. In this work, we have
investigated the function of DG during Xenopus laevis
retinogenesis, focusing on the effects of its depletion since
early developmental stages. Loss of DG function in the eye,
mediated by DG-specific morpholino oligonucleotides, leads to
ocular malformations including microphtalmia, retinal delayer-
ing and clustering of rosette-like structures that resemble
typical features of human muscle–eye–brain diseases.
Material and methods
Xenopus laevis embryos
Xenopus females were preinjected with 100 U of pregnant mare serum
gonadotrophin (Folligon, Intervet) 4–11 days prior to egg collection and with
800–1000 U of human chorionic gonadotrophin (Profase HP 2000, Serono) the
night before collection. Ovulated eggs were fertilized with testis homogenates
and allowed to develop in O.1 XMMR (1 XMMR is 0.1 M NaCl, 2 mM KCl, 1
mM MgSO4, 2 mM CaCl2, 5 mM HEPES, 0,1 mM EDTA). Jelly coats were
removed in 3.2 mM DTT, 0.2 M Tris pH 8.8. Embryos were staged according
to the Nieuwkoop and Faber-Xenopus table (Nieuwkoop and Faber, 1967).
In situ hybridization
Whole-mount in situ hybridization experiments on Xenopus embryos were
carried out as described by (Harland, 1991). Standard cRNA synthesis from
linearized plasmids using SP6, T7 or T3 RNA polymerases were carried out
incorporating digoxigenin (DIG) substituted ribonucleotides. The following
probes were used: X-DG (Lunardi and Dente, 2002); Xrx1 (Casarosa et al.,
1997); Xotx2 (Pannese et al., 1995); Xotx5 (Viczian et al., 2003); b-crystallin
((Altmann et al., 1997); hermes (Gerber et al., 1999). In situ hybridization on
sections was performed as described by Viczian et al. (2003). Histological
examinations were performed as described in Pannese et al. (1995).
Immunohistochemistry
Xenopus embryos were fixed for 1 h in 4% paraformaldehyde in 100 mM
phosphate buffer pH 7,4, then cryoprotected by immersion in 25% sucrose
overnight at 4-C. Tissues were frozen in freezing medium (OCT compound;
Sakura Finetek Europe B.V.), sectioned at 12 Am thickness in a cryostat,
collected on slides (Superfrost Plus; Menzel Glaser Germany), air dried for 30
min and finally stored at 80-C until use. Before the onset of the
immunohistochemistry procedure, sections were defrosted and blocked for 1
h at room temperature in PBS pH 7.4, 10%, inactivated lamb serum and 0.5%
Triton X-100. Sections were incubated overnight at 4-C in PBS supplemented
with 3% NGS (normal goat serum) and 0.5% Triton X-100. The primary
antibodies used were mouse anti-dystroglycan (43DAG/8D5, Novocastra
diluted 1:50), mouse anti-acetylated-tubulin antibody (SIGMA T6793 diluted
1:500), mouse anti h-1 integrin (8C8, purchased from Developmental StudiesHybridoma Bank, University of Iowa, Iowa City, IA diluted 1:10), rabbit anti-
laminin (SIGMA L-9393, diluted 1: 400), rabbit anti aPKC (Santa Cruz
Biotechnology C-20, Sc-216, diluted 1:1000). After washing in PBS, 0.2%
Tween 20, incubation with appropriate secondary antibodies was performed:
sheep anti-mouse antibody CY3 conjugated (SIGMA C2181, diluted 1:200) or
FITC conjugated (SIGMA F2883, 1:100) anti-rabbit. Nuclei were labeled with
Hoechst 33258 (SIGMA diluted 1:1000 in PBS). Slides were washed and
mounted using Aqua Poly/Mount (polisciences Inc.).
Morpholino microinjection
A specific antisense morpholino oligonucleotide (Mo-X-DG) was designed
against the 5V sequence upstream to the DG start codon of translation: 5V-
TACAGCGTAGGAGGCAGCTTGTCT-3V. Gene Tools Mo-standard (5V-
CCTCTTACCTCAGTTACAATTTATA-3V) was used for control morpholino
injections. Microinjections were performed using a Drummond ‘‘Nanoject’’
apparatus. Xenopus embryos were injected in 0.1 XMMR and 4% Ficoll 400,
and cultured overnight at 14-C in the same solution. Embryos were
subsequently transferred to 0.1 XMMR and grown at RT until they reached
the desired stage. Morpholino oligos were injected in a volume of 10 nl into the
dorsal animal pole of one of the four blastomeres in the following amounts: 17,
8, 4 and 2 ng of Mo-X-DG; 17 ng of Mo-standard (Geen Tools). 250 pg of
either green fluorescent protein or h-galactosidase RNA was co-injected with
Morpholino oligo to visualize the injected side of the embryos. When h-
galactosidase (h-gal) RNA was used as tracer, the embryos were fixed in
MEMFA for 1 h at RT, washed in 0.1 M phosphate buffer pH 6.3, and the
stained in a solution containing 32.93 mg potassium ferricyanide, 42.24 mg
potassium ferrocyanide, 15 mg salmon-Gal substrate (Roche) in 10 ml of
phosphate buffer pH6.3, for 5–60 min at 37-C. Embryos were then gradually
dehydrated with ethanol and subjected to histological examination or whole-
mount in situ hybridization.
BrdU assay
BrdU (10 mg/ml) was administered for 2 h by intra-abdominal microin-
jection (50 nl) in stage 30 embryos. Eye cryosections (12 Am) were treated with
2 N HCl (20V at RT), buffered with 5 PBS washes (3V each) and immunostained
with anti-BrdU antibody (Sigma, 1:500). The proportion of the nuclei
(visualized by Hoechst staining) that incorporated BrdU (detected by sheep
anti-mouse antibody CY3) was analyzed in both sides of 25 embryos injected
unilaterally with DGMo at 4 cell stage.
TUNEL assay
Stage 30–32 embryos were fixed in 4% PFA 45V at RT and embedded for
cryostat sectioning. To stain apoptotic cell nuclei, we used the ApopTag
Peroxidase Kit (Serologicals), following the manufacturer’s instruction.
TUNEL-positive cells were counted in eye sections of the injected and control
sides of 30 DGMo-injected embryos.
Results
Dystroglycan expression during eye development
We have previously described the pattern of DG spatio-
temporal expression in X. laevis embryos (Lunardi and Dente,
2002). Using an antisense probe for a-h dystroglycan
precursor for in situ hybridization analysis, we detected early
presence of Xenopus DG (X-DG) mRNA in a variety of tissues
and cell types of different embryological derivation. In the
present study, we have focused our analysis on DG specific
expression in the eye at different developmental stages.
Embryos were analyzed using whole-mount in situ hybrid-
ization and subsequent histological sectioning (Fig. 1). At
Fig. 1. Dystroglycan gene expression during early Xenopus laevis retinogenesis. Panels A–D are sections of in situ whole-mount hybridized embryos from stage 19
to stage 28. (A) Tangential section showing DG mRNA expression localized in the anterior neural plate at stage 19. (B–D) Transversal sections showing X-DG
mRNA expression at stage 24 (B), at stage 26 (C) and at stage 28 (D) in the optic stalk, in the presumptive pigmented epithelium and in the lens vesicle (C, D).
Panels E– IV are cryostat sections showing. X-DG immunolocalization. (E) X-DG detection at stage 28 in the neural tube and in the retina at the level of the
presumptive pigmented epithelium, the optic stalk and all around the sensorial layer of the ectoderm. (F, G) High magnification of retina sections at stage 32 showing
the presence of X-DG in the endfeet of retinal precursors in the ciliary marginal zone and in the inner limiting membrane at the vitreal border of the retina (purple
arrowheads in panel G). Green arrowheads indicate X-DG detection in the lens vesicle. (H– IV) Transverse sections of Xenopus retina at stage 45 showing X-DG
immunoreactivity at the level of retinal pigmented epithelium (white arrowhead), inner limiting membrane (purple arrowhead) and lens epithelium (green
arrowhead). Punctuated distribution of X-DG in the OPL is evidenced at high magnification in panels I, IV (same section, red detection) between the two nuclear
layers, highlighted in panel IV by Hoechst staining. Abbreviations: anp, anterior neural plate; OS, optic stalk; ppe, presumptive pigmented epithelium; nr, neural
retina; nrp, neural progenitors; lv, lens vesicle; d, dorsal; v, ventral; nt, neural tube; sle, sensorial layer of ectoderm; cmz, ciliary marginal zone; gcl, ganglion cell
layer; inl, inner nuclear layer; onl, outer nuclear layer; opl, outer plexiform layer; ipl, inner plexiform layer; ilm, inner limiting membrane.
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throughout a wide area in the anterior neural plate, which
includes the prospective eye field with the neural retinal
progenitors. At the early tailbud stage (stage 25; Fig. 1B) DG
mRNA expression was concentrated at level of the optic stalk
and of the presumptive pigmented epithelium. Later (stages
26–28; Figs. 1C, D), when the neural layer of the eye vesicle
begins to bend inwards to form the eye cup, X-DG expression
started to be detectable also in the lens vesicle.
Detection of X-DG protein at these early stages was
difficult. In contrast, from stage 28 to stage 45, its distribution
could be revealed by immunohistochemistry on cryostat
sections, using the antibody 43DAG/8D5. This antibody
recognizes the h-DG carbossi-terminus, a region highly
conserved in most vertebrate species, Xenopus included
(Lunardi and Dente, 2002). At tailbud stage (st.28), specific
immunoreactivity was detectable in the presumptive pigmented
epithelium, in the optic stalk and in the sensorial layer of the
ectoderm (Fig. 1E). Starting from stage 32, it was possible tolocalize X-DG protein in the vitreal border of the retina, at the
level of the endfeet of the retinal precursor cells (high
magnification in Figs. 1F, G) and in the lens vesicle (Fig.
1G). At stage 45, when the Xenopus retina is fully differen-
tiated, a distribution similar to the pattern already described in
several other vertebrate retinas was found (reviewed in Schmitz
and Drenckhahn, 1997). A strong and continuous immunore-
activity was evident at level of lens epithelium and of the inner
limiting membrane (Figs. 1H–IV). Weaker but reproducible
immunosignal was present as a punctate line in the outer
plexiform layer (Figs. 1I, IV). The same punctate DG
immunolocalization has been shown to correspond to specific
synaptic complexes in bovine, rat and mouse retinas (Blank et
al., 1997, 1999; Koulen et al., 1998).
Loss of dystroglycan function
Our analysis revealed presence of X-DG protein during the
early steps of eye retinogenesis in the neuroepithelium,
Fig. 2. Results of DG loss-of-function experiments. (A) Stage 45 Xenopus
embryo injected at four cells stage with 8 ng of Mo-X-DG plus 250 pg of GFP
cRNA. The injected side is indicated by the green staining; white brackets
highlight reduction of the eye size in the injected side (left) compared to the
uninjected, control side (right). (B, C) Transversal section of a stage 32 injected
embryo in which specific DG immunostaining (in red) is lost in neural tube (nt)
and eye (E) of the Mo-X-DG-injected side and in some cells of the other side,
where diffusion of the injected material sporadically happens. Fluorescent
green labeling shows the injected side of the embryo in panel C.
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question is whether X-DG was involved in the morphogenetic
processes taking place at this time. To address this question, we
used an approach of ‘‘morpholino-mediated targeted depletion’’
(Heasman, 2002). We designed a specific antisense morpholino
oligonucleotide (Mo-X-DG), complementary to the 5V end of
the X-DG transcript and fit to interfere with DG translation. In
order to avoid lethal effects deriving from a widespread
dystroglycan loss of function and to focus the analysis at eye
level, we injected Mo-XDG at the animal pole of one dorsal
blastomere, at four cells stage. In fact, this injected cell
generates one half of the anterior aspect of nervous system,
including the eye. The uninjected half of the embryo represents
the internal control of the experiment.
Mo-X-DG (17 ng, 8 ng, 4 ng and 2 ng) was injected in
combination with 250 pg of h-gal (h-galactosidase) or GFP
(green fluorescent protein) RNA, as tracers to analyze the
resulting phenotypes.
Direct analysis of the effect on X-DG protein by immuno-
histochemistry showed that the injection of 8 ng of Mo-X-DG
was sufficient to prevent dystroglycan translation (Fig. 2).
Absence of DG immunoreactivity was found in the injected
side and in rare cells of the other side, only when diffusion of
the injected material was sporadically observed (Figs. 2B, C).
Stage 45 embryos, injected with 17 ng of Mo-X-DG,
showed strong anterior malformations (data not shown) either
in the injected or uninjected sides (88%; number of
morphants, n = 82). In contrast, embryos injected with 8 ng
of Mo-X-DG exhibited microphtalmia only in the injected
side (82%, n = 111) (Fig. 2A). The injection of 4 ng showed
a consistent reduction of embryos with microphtalmia (30%,
n = 110), while no altered phenotypes were found in embryos
injected with 2 ng (n = 60). In Morpholino toxicity test,
identical doses of a standard Morpholino oligonucleotide
(Gene Tools) were injected: only few embryos showed
anterior defects (3%, n = 235).
Early phase of development: phenotypic effects of dystroglycan
depletion
Mo-mediated inactivation of X-DG produced a general
reduction of the eye size, as evaluated by external morpholog-
ical analysis of the morphants. In principle, X-DG depletion
could exert this effect by affecting the expression of genes that
pattern the eye field during early development. To address this
point, we analyzed the expression of three genes whose early
expression identifies different eye domains. Xrx1 is an eye
master gene that is expressed in the eye field region of the
anterior neural plate starting from stage 13 and marks neural
retina progenitors throughout all retinal development (Andreaz-
zoli et al., 1999; Casarosa et al., 1997). Xotx2 is a marker of
developing forebrain structures, including the eye. Its expres-
sion domain surrounds that of Xrx1 in the early developing eye
(stage 13/15) (Andreazzoli et al., 1999; Kablar et al., 1996;
Pannese et al., 1995), and later (stage 25/33) it marks the
undifferentiated neural retina (Viczian et al., 2003). b-Crystal-
lin is an early marker of the lens (Altmann et al., 1997).Comparison of the expression pattern of Xrx1, Xotx2 and b-
crystallin mRNA in Mo-X-DG-injected embryos is shown in
Fig. 3. Xotx2 and Xrx1 markers labeled their respective domains
in the injected side as well as in the control side at stage 14, thus
suggesting that Mo-mediated X-DG inactivation did not affect
the early induction of the eye field (Xotx2, n: 27; Xrx1, n: 45;
Figs. 3A, B). However, starting from stage 25 (Xotx2, 66% n:
30; Xrx1, 59%, n: 85; Figs. 3C, D) and later at stage 28 (Xotx2,
85% n: 33; Xrx1, 87%, n: 72; Figs. 3E–GV), DG depletion
caused a significant reduction of the expression domains of
either Xotx2 (Figs. 3C, E, EV) Xrx1 (Figs. 3D, F, FV), and b-
crystallin (87%, n: 48; Figs. 3G, GV) in the injected side.
DG is a transmembrane receptor that plays an active role
during the assembly of specific basement membranes, and it is
supposed to mediate signal transduction from the ECM (Henry
and Campbell, 1998). To verify the effects of DG depletion on
basement membranes of Xenopus eye, cryostat sections of the
Fig. 3. Expression of eye markers in X-DGmorphants. Xotx2 (A, C, E, EV), Xrx1 (B, D, F, FV) and b-crystallin (G, GV) mRNA expression was detected by BMP purple
(blue staining) in Mo-X-DG-injected embryos at stage 14 (A, B), 25 (C, D) and 28 (E–GV). Nuclear beta-gal staining (red) was used to trace the side of injection. Panels
A–D show both injected and uninjected sides in frontal views. Panels E–GV show lateral view of uninjected (E, F, G) and injected (EV, FV, GV) sides, respectively. No
changes in the expression domains of Xotx2 (A) and Xrx1 (B) are detectable between the two sides at stage 14. White brackets highlight the decrease of Xotx2 (C) and
Xrx1 (D) expression in the eye of the injected sides at stage 25. Decrease is evident also at stage 28 (compare panel E to EV and F to FV); beta-crystallin expression is also
dramatically reduced in the injected side (compare panel G to GV). Mo-X-DG injection completely abolishes also Xotx2 rostral expression domain in panels E to EV.
A. Lunardi et al. / Developmental Biology 290 (2006) 411–420 415anterior region of morphants at stage 32 were analyzed by
immunostaining with specific laminin and integrin antibodies
(Fig. 4). The anti-laminin antibody used in this analysisFig. 4. Cryostat sections of Xenopus retina immunolabeled with polyclonal antibody
integrin (A–G: red labeling) and polyclonal antibody against aPKC (H–K, red label
stage 32. The injected side in panels J and K was traced by GFP. Laminin and integr
of pigmented epithelium (PE), at the border of vitreal cavity in the inner limiting me
these laminae was detected in the injected sides of morphants (arrows in panels B, C,
E) was affected in the injected sides of morphants (B, C, G). High magnifications (D
Localization of aPKC at the apical side of the retinal neural precursors (nrp), underne
injected eye (J, K). At higher magnification, the aPKC staining of retinas in the corecognizes the heterotrimer Lam1 (including a 1, h1, g1
subunits) that is present in the two main retinal basement
membranes: the Bruch’s membrane at the bases of pigmentedagainst Lam1 (A–D and F: green labeling); monoclonal antibody against h1-
ing). Control side (A, D, E, H, I) and injected side (B, C, F, G, J, K) of retinas at
in were co-detected (yellow signal) in the Bruch’s membrane (BrM) at the bases
mbrane (ILM) and in the lamina surrounding the lens. Severe disorganization of
F). Integrin staining, which showed a radial-like pattern in the control sides (A,
–G) highlight the histology of the retina at its most marginal side near the lens.
ath the pigmented epithelium (PE) was visible either in control (H, I) or in Mo-
ntrol (I) and injected (K) sides was comparable.
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vitreal cavity (Libby et al., 2000). The anti-integrin antibody
8C8 is specific for the h1-integrin subunit, which spans the
entire width of the retina along the neuroepithelial precursors
and is especially abundant at the site of contact of the retinal
inner limiting membrane (ILM), where it acts as a laminin
receptor (Li and Sakaguchi, 2002; Li et al., 2004). In the
injected side of X-DG morphants, a delocalization of laminin
was evident in 75% of morphants (n = 60). Figs. 4B and C
show two examples of the phenotypes obtained after injection
of 8 ng of Mo-X-DG, compared to control (Fig. 4A).
Basement laminae that form continuous and discrete sheaths
in the control side (Figs. 4A, D, E) were frequently disrupted
and/or disorganized in the injected side (arrows in Figs. 4B,
C, F, G), either between the lens vesicle and the retinal border
or under the developing pigmented epithelium, at level of the
Bruch’s membrane. Furthermore, h1-integrin immunoreactiv-
ity, detectable with a radial-like pattern at the control side
(Figs. 4A, D, E), resulted disturbed in the contralateral,
injected side (Figs. 4B, C, F, G), even if the analysis of a
large number of sections showed that the total protein level
was unvaried.
In order to verify if the polarity of neuroepithelial precursors
was also altered, the localization of aPKC, a marker of apical
side of embryonal epithelia, was analyzed using the antibody
C-20 that is raised against both PKC E and ~ (Horne-
Badovinac et al., 2001); aPKC resulted correctly localized at
the apical side of the retina underneath the presumptive
pigmented epithelium of all the morphants analyzed (Figs.
5H, K).Fig. 5. Retinal delayering in DG morphants. (A–E) control sides; (AV–EV) Mo-X-DG
from stage 45 embryos: (A, AV) Xotx5 mRNA; (B, BV) Xotx2 mRNA; (C, CV) hermes
panels D and DV. In panel A, blue and white arrowheads indicate photoreceptors an
indicates ectopic hermes expression in panel CV. Yellow arrowheads indicate ectopLate phase of development: phenotypic effects of dystroglycan
depletion
At stage 45, when Xenopus eyes are fully developed, severe
retinal morphological disorders were detected in the injected
side of 43% of the morphants (n: 117). Evaluation of the late
effects was carried out using specific markers of the different
retinal cell types (Gerber et al., 1999; Viczian et al., 2003). As
previously reported, in the control side Xotx5 expression
marked photoreceptors and a sub-type of bipolar cells in the
mature retina (Fig. 5A), Xotx2 was expressed in bipolar cells
(Fig. 5B) and hermes specifically identified ganglion cells in
the GCL (Fig. 5C). Finally, nervous fibers of both OPL and
IPL were revealed by immunostaining of acetylated-N-tubulin
(Fig. 5D).
One of the most evident late effects of Mo-X-DG injection
was the presence of ‘‘rosette-like structures’’ (green arrowheads
in Figs. 5AV–DV), which were made of misplaced photorecep-
tors exposing their external segments inside the hollow space
of the rosette. In Mo-X-DG morphants, these structures were
highlighted by expression of Xotx5, which was detected
outside the ONL (green arrowheads in Fig. 5AV). Delayering
of Mo-X-DG retinas was also confirmed by the pattern of
Xotx2 labeling (Fig. 5BV), which was dramatically disturbed
compared to control retinas (Fig. 5B). In addition to photo-
receptors and bipolar cells, ganglion cells were also misplaced,
even if less frequently: in 30% (n = 117) of the Mo-X-DG
retinas, hermes was detected under the pigmented epithelium
(red arrowhead in Fig. 5CV) and/or near the rosette-like
structures (not shown). Nonetheless, neuronal differentiation-injected sides. Expression of markers for specific cell types in retinal sections
mRNA; (D, DV) N-tubulin. (E, EV) Hoechst nuclear staining of sections shown in
d bipolar cells. Green arrowheads show rosette-like structures. Red arrowhead
ic nervous fibers in panel DV and the corresponding position in panel EV.
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injection. Nervous fibers were detected by immunostaining
with acetylated-N-tubulin in Mo-X-DG retinas (Fig. 5DV), even
if their pattern was dramatically disorganized when compared
to controls (Fig. 5D). Notably, migration of retinal neuronal
cells was altered: ectopic nervous fibers (as those indicated by
yellow arrowhead in Fig. 5DV) were often found close to
rosette-like structures (green arrowhead) and near misplaced
hermes positive cells (not shown).
Discussion
The role of DG has been extensively studied in muscles, in
view of its association to dystrophin and the involvement in
muscular dystrophies. Recently, several findings have revealed
a previously unrecognized role for DG in early events of
neurogenesis, in migration and targeting of cell surface proteins
that give plausible explanations of the histopathological neural
features frequently present in congenital muscular dystrophies
(Michele et al., 2002; Moore et al., 2002). Mental deficits are
often coupled to ocular defects, such as retinal dysplasia with
detachment and delayering, microphtalmia and cataract
(Dubowitz, 2000; Hino et al., 2001; Kano et al., 2002; Toda
et al., 2000).
In order to investigate the role of DG and the effects of its
depletion during vertebrate eye development, we have first
characterized its expression pattern in the embryonic and adult
Xenopus eyes. We found that X-DG mRNA is already
detectable at neurula stage in the eye field and later at tailbud
stage, it is mainly concentrated in presumptive pigmented
epithelium, in developing retina, in lens vesicle and optic stalk.
Immunostaining of X-DG protein was detectable, at tailbud
stage, as a concentrated signal on lens vesicle, on the vitreal
border of the retina in the endfeet of neuroepithelial progenitors
and on cells fated to form the pigmented epithelial layer in
front to Bruch’s membrane. Early expression of DG protein in
the endfeet of neuroepithelial progenitors has been also
observed in embryonic avian retina at stages preceding the
differentiation of neurons or glial cells (Blank et al., 2002).
This observation and the joined presence of other DAP
components (i.e., dystrophin) lead the authors to suppose that
DG could play a role in the developing retina similar to that
well characterized in muscle (Blank et al., 2002; Schmitz and
Drenckhahn, 1997). Beyond this structural role, later in the
adult retina, DG is supposed to be involved in visual signal
transduction. This is assumed on the bases of its specific
localization in the finger-like extensions protruding from
photoreceptors (Blank et al., 1997, 1999; Koulen et al.,
1998). Indeed, we found that DG protein distribution in fully
differentiated Xenopus eye (stage 45) was similar to the pattern
described in other vertebrate species (Blank et al., 1997, 1999;
Koulen et al., 1998). DG immunoreactivity appeared as a
punctate staining in correspondence of the OPL, while it was
mainly concentrated, as a continuous layer, at the level of ILM,
lens and retinal pigmented epithelium.
To gain more insight into the role of DG in the retina, we
targeted morpholino-mediated DG depletion to the anteriorembryonic nervous system. The absence of DG immunoreac-
tivity in the Mo-injected side of the embryos proved the
blocking effect of morpholino injection on DG protein
production. A main morphological effect of DG depletion
was microphtalmia, which is an ophthalmological feature often
described also in human CMD (Cormand et al., 2001; Hino et
al., 2001). The precise mechanism that causes the eye size
reduction has not been so far elucidated in this kind of diseases.
In principle, the reduction of eye size could be exerted by
different mechanisms, such as induction of a premature
differentiation, reduced rate of proliferation of cell progenitors
or induction of unscheduled apoptosis. To address these
hypotheses, we investigated if deregulation of genes that
pattern the eye field, such as Xrx1 (Andreazzoli et al., 2003)
or Xotx2 (Zuber et al., 2003), was detectable in the injected
side. In contrast, at stage 14, the expression pattern of both
genes was unaffected, suggesting that DG depletion does not
involve changes of identity of the early eye field. However, at
later stages, a reduction of the expression domains of either
Xrx1, Xotx2 or h-crystallin was evident in the injected side. In
order to distinguish if the reduction was due to diminished cell
proliferation or increased apoptosis, we performed specific
assays shown in Fig. 6. The number of injected cells
(highlighted by the green GFP fluorescence), which incorpo-
rated BrdU and therefore were actively proliferating, was lower
than the number detected in the control side, as expected
considering the decrease of expression of Xrx1, a main
determinant of the proliferation of retinal progenitors
(Andreazzoli et al., 2003; Casarosa et al., 2003) (Figs. 6A,
D). However, the difference between the two sides was lower
than 10% (Fig. 6G) and cannot fully explain the marked
microphtalmia associated to DG depletion. In contrast, the
number of apoptotic cells, measured by TUNEL assay, was
almost 10 times higher in the MO-injected side compared to the
control side (Figs. 6E, F, H), suggesting that this is the
mechanism deriving as secondary effect of the basal mem-
branes (BM) disorganization.
Indeed, in addition to microphtalmia, two main phenotypes
were associated to DG depletion. An early effect was the
disorganization of the basal laminae of both retina and lens. A
later effect consisted of a dramatic delayering of the neural
retina. The two effects might be causally related. Severe
perturbations of the ILM and of the Bruch’s membrane were
detected by analysis of the immunoreactivity to laminin-1
during early eye development. The two membranes were still
present in the DG-depleted eyes at stage 32, but their structure
was discontinuous and, in some cases, fainter compared to
control.
DG and h1-integrins are high affinity receptors of laminin-
1, one of the main components of the ECM. DG and h1-
integrins bind to distinct region of the subunit a of the laminin-
1: the globular domains a1LG4-5 and a1LG1-3, respectively.
These individual domains are supposed to play different roles
in basal lamina organization and signaling (Ferletta et al., 2003;
Henry et al., 2001; Scheele et al., 2005). In mouse embryonic
stem cells, it has been shown that DG-laminin interaction was
essential for the initial binding of laminin to cell surface; in
Fig. 6. Effects of the unilateral injection of Mo-X-DG (8 ng) at stage 4 cells on
the apoptosis and cell proliferation of the eye. (A–F) Eye sections of stage 32
embryos. Pe: pigmented epithelium. Detection of GFP, which was used as
tracer, is shown in panels B, D, F. Panels A–D show BrdU immunodetection
(red nuclei) in the control side (A, C) and Mo-injected side (Mo, B, D) of the
embryo. Hoechst counterstaining labels all nuclei in panels C, D. Panels E and
F show TUNEL detection of apoptotic nuclei (brown staining) in control (E)
and Mo-X-DG-injected side (F), respectively. Sections of Mo-X-DG injected
eyes always displayed a significantly higher number of TUNEL-positive cells
than sections of uninjected, contralateral eyes. Eyes injected with control-Mo
had the same number of TUNEL-positive cells than uninjected eyes (not
shown). The numbers of BrdU-positive nuclei in control and Mo-X-DG-
injected (Mo) retinas, expressed as percent over the total number of cells
analyzed (control: n = 550, Mo: n = 514), are compared in panel G. The
average number of TUNEL-positive cells per eye section (n = 120 sections) in
control and Mo-X-DG-injected retinas is compared in panel H. Bars indicate
SE in panel G and SEM in panel H. Differences between control and Mo are
significant in panel G (t test: P = 0.008904109) and in panel H (t test: P =
8.997E–06).
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matrix assembly (Henry et al., 2001). On the other hand, in
mice lacking only the DG/laminin binding domain a1LG4-5,
the assembly of early basement membranes was normal,
allowing embryos implantation, even if subsequent stem cells
polarization and differentiation in epithelia failed (Scheele et
al., 2005).
Basal laminae have established roles in correct development
and differentiation of the epithelia. The distribution pattern of
laminin-1 in the ILM and Bruch’s membrane, observed in the
injected side of X-DG morphants, suggests that DG presence is
not essential for the assembly of these basal laminae; rather,
DG seems important for maintaining the firm connections for
ECM-cells adhesion. We speculate that the dramatic disorga-
nization of the radial-like pattern of h-integrins in the DG-
depleted eyes at stage 32 could be just caused by attenuation of
ECM-cells adhesion.A role of DG in supporting ECM-cells adhesion could be
crucial for later retinal morphogenesis. Indeed, we have
observed that absence of DG function, at early stages of
Xenopus eye development, lead to consequent morphogenetic
and histological alterations, later. The differentiation of distinct
retinal cell types such as ganglion cells, photoreceptors and
bipolar cells was not impaired in Mo-X-DG morphants, as
assessed by hybridization with specific cell markers (hermes;
Xotx5; Xotx2). In contrast, the layering of definite cell types
was damaged by anomalous localization of photoreceptors and
ganglion cells, which were scattered throughout the retina or
aggregated in rosette-like structures.
Li and co-authors have recently shown analogous alterations
in Xenopus retina, following perturbation of integrins function.
Injection of h1-integrin blocking antibodies or specific
inhibitors into Xenopus optic vesicle, determined disruption
of retinal development, rosette clustering with ectopic photo-
receptors and retinal delayering (Li and Sakaguchi, 2004).
Likewise, inhibition of BM adhesive function of h-integrins in
embryonic chick neural retina determined alterations of cell
morphology and increased apoptosis (Leu et al., 2004).
Finding comparable retinal phenotypes following inhibition
of DG or integrin functions is not surprising, taking into
account their common role in cell adhesion and ECM
transduction signaling. Both receptors indeed, after ligand
stimulation, induce phosphorylation of proteins on tyrosine
residues (Lewis et al., 1996; Wary et al., 1998; James et al.,
2000). Indeed, it has been shown that specific inhibition of
protein tyrosine kinase activity in Xenopus retina altered cell
adhesion and migration, causing disturbed retinal development
(Li et al., 2004). Evidently, the correct attachment of the retinal
progenitors at the BM is a crucial event that is controlled at
multiple levels; it is sufficient to perturb one of the key
components to severely interfere with the successive develop-
ment steps.
Differentiation of retinal cell types is a complex process that
starts at the time of cell cycle arrest, when most retinal cells
start to migrate along polarized neuroepithelial progenitors to
differentiate and form specific layers. Polarized precursors are
essential to guide the cells to the right position. We may
hypothesize that interruptions in the continuous sheath of
laminins on retinal vitreal border and pigmented epithelium of
X-DG morphants and the consequent detachment of retinal
precursors from the BM could alter their migration. Ganglion
cells are the first type to differentiate: they migrate from the
apical side to the basal vitreal border of the retina, forming the
ganglion cell layer. In fact, in a high percentage of X-DG
morphants, ganglion cells were spread throughout the retina or
remained at level of photoreceptors layer.
Genetic evidences deriving from a group of zebrafish
mutants (nok, has, ncad) have suggested that loss of polarity
of retinal precursors may affect the correct layering of retinal
neurons (Pujic and Malicki, 2004). Furthermore, RNAi-
mediated loss of function of a DG homolog protein in
Drosophila resulted in expanded expression of some apical
markers in progenitors of epithelial cells (Deng et al., 2003). In
order to verify if perturbation of cell polarity was implicated in
A. Lunardi et al. / Developmental Biology 290 (2006) 411–420 419Mo-generated phenotypes, we analyzed the distribution of
aPKC, a typical apical marker (Horne-Badovinac et al., 2001).
In Xenopus DG morphants, the apical polarity of neuroepithe-
lial precursors cells was not significantly altered, as shown by
the correct localization at the ventricular side of the embryonic
retina of the apical marker aPKC (Figs. 5H, K).
Thus, these observations suggest that retinal delayering
observed after DG depletion in Xenopus might be functionally
related to weakening of cell adhesion to basal membranes,
which in turn would impair the anchoring of retinal progeni-
tors. This mechanism reminds that suggested in CNSDG-null or
mydLarge mice, where DG perturbation is associated to
disruption of basal laminae, misplaced neurons and abnormal
cortical cells layering (Michele et al., 2002; Moore et al.,
2002). Our findings underscore the importance of DG in eye
morphogenesis and allow to plan further use of Xenopus as
model system for studying human diseases associated to
affected DG.
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